Newsbot

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation

Richard Francis, Tevas President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time) Richard Francis, Tevas President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time)

Inside Starbucks’ bold plan to reclaim its magic

After roughly 15 months of the Covid pandemic lockdowns, I sat with my laptop outside a Starbucks in West Palm Beach. It seemed like a little thing, but when I realized how long I had been surviving off of drive-thru and pickup, I started to cry. Writing at Starbucks, or sometimes local coffee ...

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

NEW YORK and PARSIPPANY, N.J., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a funding agreement of up to $500 million to accelerate the clinical development of Teva’s anti-IL-15 antibody, TEV-408. IL-15 is a key cytokine involved in multiple immune-mediated disease pathways. Emerging Phase 1b data from the ongoing TEV-‘408 vitiligo study provides prel...

Record Revenue And Backlog Volatility Might Change The Case For Investing In MasTec (MTZ)

In recent trading, MasTec reported record third-quarter revenue and a larger backlog, yet management cautioned that permitting delays and shifting customer spending can cause significant quarter-to-quarter swings in margins and cash flow.This mix of strong activity and operational uncertainty highlights how timing issues in major infrastructure projects can materially influence MasTec’s near-term financial profile.Next, we’ll examine how these permitting and spending-related margin swings...

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

PARSIPPANY, N.J., and NEW YORK, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Royalty Pharma plc (Nasdaq: RPRX), today announced a funding agreement of up to $500 million to accelerate the clinical development of Teva’s anti-IL-15 antibody, TEV-’408. IL-15 is a key cytokine involved in multiple immune-mediated disease pathways. Emerging Phase 1b data from the ongoing TEV-‘408 vitiligo study provides pr...

52-year-old restaurant closes as owners make heartfelt plea

My grandfather bought the land where our family business, Lynn Ladder & Scaffolding, still operates. Thats a prescient move that provides protection against business slowdowns and having your location sold out from underneath you. Its likely that our 80-year-old family business, which mostly ...

ROUNDUP 2: Wadephul auf Island - Themen Grönland und Arktis-Sicherheit

REYKJAVIK (dpa-AFX) - Außenminister Johann Wadephul macht auf seinem Flug in die USA einen Zwischenstopp auf Island. Auf der nur knapp 300 Kilometer südöstlich von Grönland liegenden Insel kam der CDU-Politiker mit seiner Kollegin Thorgerdur Katrín G...

Global airline cancels all flights in Chapter 7 liquidation plan

The first airline liquidations of 2026 have already started emerging. The first airline to formally cease operations in 2026 is Royal Air Philippines — the Manila-based charter and cargo airline more commonly referred to as Royal Air received licensing to run commercial flights in 2017 and quickly ...

ROUNDUP 2: Zugang zum Internet im Iran weiter blockiert

TEHERAN (dpa-AFX) - Die iranische Führung blockiert das Internet wegen der landesweiten Massenproteste jetzt den vierten Tag in Folge. Wie die auf Netzsperren spezialisierte Organisation Netblocks weiter mitteilte, beträgt die Verbindung zur Außenwel...

Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today provided an update on its latest progress, developments plans and expected 2026 milestones, which it will present at the 44th Annual J.P. Morgan Healthcare Conference in S...

US-Medien: Museum streicht Hinweis zu Trumps Amtsenthebungsverfahren

WASHINGTON (dpa-AFX) - Die National Portrait Gallery in Washington hat US-Medienberichten zufolge einen Text entfernt, der unter anderem die beiden Amtsenthebungsverfahren gegen US-Präsident Donald Trump thematisierte. Der Schritt erfolgte, als das M...

Moskaus Krieg gegen Kiew bald länger als gegen Berlin

MOSKAU/KIEW (dpa-AFX) - Der russische Angriffskrieg gegen die Ukraine dauert inzwischen genauso lange wie der Große Vaterländische Krieg der Sowjetunion gegen Hitler-Deutschland. Auf diese Statistik verwies neben dem ukrainischen Präsidenten Wolodymy...

Dave Ramsey bluntly warns Americans on 401(k)s

Radio show host and bestselling personal finance author Dave Ramsey has a big caution for American workers, and in my 30 years of experience, I can say I agree with him. If your employer offers a 401(k) plan, especially one with matching funds, take them up on it the second you get the chance. "If ...

Bit Digital Aktie: Spannende Wette auf starken Trend bei Ethereum und KI!

Kulmbach (www.aktiencheck.de) - Bit Digital-Aktienanalyse von "Der Aktionär":Alfred Maydorn vom Anlegermagazin "Der Aktionär" nimmt im Interview mit "Der Aktionär TV" die Aktie von Bit Digital Inc. (ISIN: KYG1144A1058, WKN: A2QFQV, Ticker-Symbol: BIV, NASDAQ-Symbol: BTBT) unter die Lupe.Die Aktie von Bit Digital habe sich von ihrem tiefen Sturz noch nicht erholt. [mehr]